Opus Genetics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.01

+0.43 (+16.67%)

As of Feb 8, 2:05 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 14 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +671.1% upside

Low Target $16.63

Average Target $23.21

High Target $31.03

Current Price $3.01

Current
$3.01

Target
$23.21

$16.63 $23.21 avg $31.03

Scenario Analysis

Bear Case

$16.63

452.5%

Low target

Base Case

$23.21

+671.1%

Avg target

Bull Case

$31.03

+930.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$26.53

-88.7% from high

52-Week Low

$18.74

+-83.9% from low

Target vs 52W High

$23.21

-12.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%